Prednisolone 40 mg

DRUG2 trials

Sponsors

AstraZeneca, Asian Institute of Gastroenterology, India

Conditions

Alcoholic HepatitisRheumatoid Arthritis

Phase 1

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.

CompletedNCT02760316

AstraZenecaRheumatoid Arthritis

Start: 2016-05-02End: 2017-09-11Target: 64Updated: 2017-10-17

Phase 3

Short Course Steroids in Alcohol Associated Hepatitis

CompletedNCT06919458

Asian Institute of Gastroenterology, IndiaAlcoholic Hepatitis

Start: 2025-04-07End: 2026-08-15Updated: 2026-09-01

Related Papers

Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials.

2019-12-0915 citations